Home » Sagent Pharmaceuticals Announces FDA Approval of Polymyxin B for Injection, USP
Sagent Pharmaceuticals Announces FDA Approval of Polymyxin B for Injection, USP
Sagent Pharmaceuticals announced FDA approval of polymyxin B for injection, USP, an antibacterial drug, in 500,000 units per vial, latex-free glass vials.
IEWY News
IEWY News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May